Back to List

Companion Diagnostics โ€” Integration of Biomarker Tests with Therapeutic Labels

This article explains the concept and the limits of the evidence. It does not provide diagnostic, testing, or treatment decisions for an individual patient.

Advanced
|
6min
|
Verified (2026-08-21)
companion diagnosticbiomarkerFDAtherapeutic labeling
Progress0/19 (0%)

Companion Diagnostics โ€” Integration of Biomarker Tests with Therapeutic Labels

Why this matters

A companion diagnostic is not merely a biomarker test associated with treatment response. It is a regulated device that provides essential information for the safe and effective use of a specific therapeutic agent, including its indication, specimen type, platform, and cutoff values. Research tests or other assays targeting the same gene cannot be automatically substituted as equivalents. In practice, decisions must be made by consulting the most recent device labeling and therapeutic labeling applicable within the relevant jurisdiction. This concept does not propose individualized treatment choices for specific patients.

Interpretation boundary

This article explains the concept and the limits of the evidence. It does not provide diagnostic, testing, or treatment decisions for an individual patient.

References

๐Ÿ’ฌ Questions & Comments

0 comments

You can post without signing in. Guest comments cannot be edited or deleted by their author.

0/2000

Loading...